Baxter to produce A/H1N1 pandemic vaccine on large scale
Published: 2009-08-12 06:57:00
Updated: 2009-08-12 06:57:00
Baxter International Inc. said on August 7 it completed production of its first commercial batches of C A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities to get appropriate authorizations.
The company said the vaccine was developed a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
